These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10953296)

  • 1. Role of carbohydrate moiety in granulocyte colony stimulating factor.
    Sakagami H; Tajima M; Takayama F; Oi T; Kusama K; Yamamoto T; Saito M; Murayama J
    Anticancer Res; 2000; 20(4):2355-9. PubMed ID: 10953296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycosylation of recombinant human granulocyte colony stimulating factor: implications for stability and potency.
    Nissen C
    Eur J Cancer; 1994; 30A Suppl 3():S12-4. PubMed ID: 7535065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Actin polymerization in neutrophils from donors of peripheral blood stem cells: divergent effects of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factor.
    Carulli G; Mattii L; Azzarà A; Brizzi S; Galimberti S; Zucca A; Benedetti E; Petrini M
    Am J Hematol; 2006 May; 81(5):318-23. PubMed ID: 16628714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superior mobilisation of haematopoietic progenitor cells with glycosylated G-CSF in male but not female unrelated stem cell donors.
    Fischer JC; Frick M; Wassmuth R; Platz A; Punzel M; Wernet P
    Br J Haematol; 2005 Sep; 130(5):740-6. PubMed ID: 16115131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte colony-stimulating factor promotes functional maturation of O-2 generating system during differentiation of HL-60 cells to neutrophil-like cells.
    Yamaguchi T; Yamaguchi T; Hayakawa T
    Arch Biochem Biophys; 1998 May; 353(1):93-100. PubMed ID: 9578604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosylation interference on RhoA activation: focus on G-CSF.
    Mattii L; Battolla B; Azzarà A; D'Urso G; Montali U; Petrini M
    Leuk Res; 2011 Feb; 35(2):265-7. PubMed ID: 20573400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three types of recombinant human granulocyte colony-stimulating factor have equivalent biological activities in monkeys.
    Tanaka H; Tanaka Y; Shinagawa K; Yamagishi Y; Ohtaki K; Asano K
    Cytokine; 1997 May; 9(5):360-9. PubMed ID: 9195136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factor differently modifies actin polymerization in neutrophils.
    Zucca A; Brizzi S; Riccioni R; Azzarà A; Ghimenti M; Carulli G
    Clin Ter; 2006; 157(1):19-24. PubMed ID: 16669548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosylated or non-glycosylated G-CSF differently influence human granulocyte functions through RhoA.
    Mattii L; Azzarà A; Fazzi R; Carulli G; Chimenti M; Cecconi N; Galimberti S; Petrini M
    Leuk Res; 2005 Nov; 29(11):1285-92. PubMed ID: 15916805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in functional activity and antigen expression of granulocytes primed in vivo with filgrastim, lenograstim, or pegfilgrastim.
    Ribeiro D; Veldwijk MR; Benner A; Laufs S; Wenz F; Ho AD; Fruehauf S
    Transfusion; 2007 Jun; 47(6):969-80. PubMed ID: 17524085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lenograstim and filgrastim effects on neutrophil motility in patients undergoing chemotherapy: evaluation by computer-assisted image analysis.
    Azzarà A; Carulli G; Rizzuti-Gullaci A; Capochiani E; Petrini M
    Am J Hematol; 2001 Apr; 66(4):306-7. PubMed ID: 11279646
    [No Abstract]   [Full Text] [Related]  

  • 12. Glycosylation improves the priming effect exerted by recombinant human granulocyte colony-stimulating factor (lenograstim) on human neutrophil superoxide production.
    Decleva E; Cramer R; Zabucchi G
    Int J Tissue React; 1995; 17(5-6):191-8. PubMed ID: 8835629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced dose of lenograstim is as efficacious as standard dose of filgrastim for peripheral blood stem cell mobilization and transplantation: a randomized study in patients undergoing autologous peripheral stem cell transplantation.
    Ataergin S; Arpaci F; Turan M; Solchaga L; Cetin T; Ozturk M; Ozet A; Komurcu S; Ozturk B
    Am J Hematol; 2008 Aug; 83(8):644-8. PubMed ID: 18508321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate inhibits superoxide production and chemotaxis in neutrophils activated by granulocyte colony-stimulating factor.
    Okuda A; Kubota M; Sawada M; Koishi S; Kataoka A; Bessho R; Usami I; Lin YW; Adachi S; Furusho K
    J Cell Physiol; 1996 Jul; 168(1):183-7. PubMed ID: 8647914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo stimulation of neutrophil function by lenograstim (glycosylated rHuG-CSF) in oncohematologic patients: results of a phase I trial.
    Fossat C; Stoppa AM; Sainty D; Blaise D; Viens P; Bayssas M; Yver A; Juhan-Vague I; Maraninchi D
    Stem Cells; 1994 May; 12(3):322-8. PubMed ID: 7521242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor promote malignant growth of cells from head and neck squamous cell carcinomas in vivo.
    Gutschalk CM; Herold-Mende CC; Fusenig NE; Mueller MM
    Cancer Res; 2006 Aug; 66(16):8026-36. PubMed ID: 16912178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte colony-stimulating factor (filgrastim) treatment primes for increased ex vivo inducible prostanoid release.
    von Aulock S; Boneberg EM; Diterich I; Hartung T
    J Pharmacol Exp Ther; 2004 Feb; 308(2):754-9. PubMed ID: 14610236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosylated vs non-glycosylated granulocyte colony-stimulating factor (G-CSF)--results of a prospective randomised monocentre study.
    Bönig H; Silbermann S; Weller S; Kirschke R; Körholz D; Janssen G; Göbel U; Nürnberger W
    Bone Marrow Transplant; 2001 Aug; 28(3):259-64. PubMed ID: 11535993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of two different rG-CSF preparations in the treatment of patients with severe congenital neutropenia.
    Carlsson G; Ahlin A; Dahllöf G; Elinder G; Henter JI; Palmblad J
    Br J Haematol; 2004 Jul; 126(1):127-32. PubMed ID: 15198743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral blood stem cell yield in 400 normal donors mobilised with granulocyte colony-stimulating factor (G-CSF): impact of age, sex, donor weight and type of G-CSF used.
    Ings SJ; Balsa C; Leverett D; Mackinnon S; Linch DC; Watts MJ
    Br J Haematol; 2006 Sep; 134(5):517-25. PubMed ID: 17018030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.